NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pillar Biosciences

Pillar Biosciences

Private
Natick, MassachusettsHealthcare & Life Scienceshttps://www.pillarbiosci.com/

Last Round

Strategic

May 27, 2025

Total Funding Raised

$102.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pillar Biosciences is a biotechnology company that develops and manufactures targeted next-generation sequencing (NGS) panels and bioinformatics software for clinical cancer diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

next-generation sequencingNGSclinical oncologytumor profilinggenomic testingprecision medicinebioinformatics softwaredecentralized testingmolecular diagnosticsNGS library preparationin-house testingliquid biopsyIVDcompanion diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pillar Biosciences Comps

Public and private peers based on sector, stage, and business model.

Pillar Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pillar Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 27, 2025
Series DMay 1, 2021
Series CMay 12, 2020
Series BNov 1, 2018
Series AMay 11, 2016

Pillar Biosciences Investors

Notable investors and investment history

Pillar Biosciences investors
InvestorRounds
HB VenturesSeries C
Soleus CapitalStrategic
ORI CapitalSeries A, Series C
Infinity GroupSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 46% MoM, reaching 4.4K.

  • Apr 2, 2026

    Partnered with CellCarta for global tumor profiling.

Pillar Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pillar Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pillar Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts
Employee Range69
Year Founded2014
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.